• Product NameRevefenacin
  • CasNo. 864750-70-9
  • MFC35H43N5O4
  • MW597.758
  • Purity
  • Appearance
  • Packing
  • Contact usInquiry

Product Details

CasNo: 864750-70-9

MF: C35H43N5O4

High quality purity >99% Revefenacin 864750-70-9 for sale

  • Molecular Formula:C35H43N5O4
  • Molecular Weight:597.758
  • Melting Point:125 °C 
  • Boiling Point:777.5±60.0 °C(Predicted) 
  • PKA:13.34±0.70(Predicted) 
  • PSA:108.21000 
  • Density:1.26±0.1 g/cm3(Predicted) 
  • LogP:5.48510 

864750-70-9 Relevant articles

Preparation method of revefenacin

-

Paragraph 0085; 0087; 0091-0093; 0145-0161, (2021/07/17)

The invention discloses a preparation me...

Preparation methods of revefenacin intermediate and revefenacin

-

, (2021/05/26)

The invention relates to a synthesis met...

New rafenacin intermediate, active electrophilic building block thereof and new preparation method of rafenacin

-

, (2021/04/26)

The invention provides a new rafenacin i...

Revefenacin intermediate, preparation method thereof and preparation method of revefenacin

-

, (2019/12/25)

The invention relates to the field of ph...

864750-70-9 Process route

[1,1'-biphenyl]-2-yl-isocyanate
17337-13-2

[1,1'-biphenyl]-2-yl-isocyanate

biphenyl-2-yl carbamic acid 1-(2-{[4-((4 carbamoylpiperidin-1-yl)methyl)benzoyl]N-methylamino}ethyl)piperidin-4-yl ester
864750-70-9

biphenyl-2-yl carbamic acid 1-(2-{[4-((4 carbamoylpiperidin-1-yl)methyl)benzoyl]N-methylamino}ethyl)piperidin-4-yl ester

Conditions
Conditions Yield
Multi-step reaction with 5 steps
1.1: 12 h / 70 °C
1.2: 12 h / 20 - 40 °C / Inert atmosphere
1.3: pH 12
2.1: 2-methyltetrahydrofuran / 3 - 30 °C
2.2: 7 - 20 °C
2.3: 0.33 h / 20 °C
3.1: hydrogen / palladium 10% on activated carbon / 2-methyltetrahydrofuran; methanol / 3.02 h / 760.05 Torr / Sealed tube
4.1: 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride / 2-methyltetrahydrofuran / 20 °C
4.2: 0.17 h
5.1: isopropyl alcohol / 60 °C
5.2: 2.08 h / 18 - 25 °C
5.3: 0.25 h
With hydrogen; 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride; palladium 10% on activated carbon; In 2-methyltetrahydrofuran; methanol; isopropyl alcohol;
C<sub>17</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>

C17H23N3O3

4-piperidyl N-(2-biphenyl)carbamate
171722-92-2

4-piperidyl N-(2-biphenyl)carbamate

biphenyl-2-yl carbamic acid 1-(2-{[4-((4 carbamoylpiperidin-1-yl)methyl)benzoyl]N-methylamino}ethyl)piperidin-4-yl ester
864750-70-9

biphenyl-2-yl carbamic acid 1-(2-{[4-((4 carbamoylpiperidin-1-yl)methyl)benzoyl]N-methylamino}ethyl)piperidin-4-yl ester

Conditions
Conditions Yield
C17H23N3O3; 4-piperidyl N-(2-biphenyl)carbamate; With acetic acid; sodium sulfate; In tetrahydrofuran; at 25 ℃; for 2h;
With sodium tris(acetoxy)borohydride; In tetrahydrofuran; at 0 - 25 ℃; for 2h; Temperature;
85%

864750-70-9 Upstream products

  • 39546-32-2
    39546-32-2

    4-carboxamidopiperidine

  • 864760-28-1
    864760-28-1

    biphenyl-2-yl-carbamic acid 1-{2-[(4-formylbenzoyl)methylamino]ethyl}piperidin-4-yl ester

  • 4727-72-4
    4727-72-4

    1-benzyl-4-hydroxypiperidine

  • 17337-13-2
    17337-13-2

    [1,1'-biphenyl]-2-yl-isocyanate

Relevant Products